Voyager Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
VYGR Nasdaq 8731 https://www.voyagertherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Voyager Therapeutics Inc

Voyager Therapeutics to Present at the Jefferies Healthcare Conference - Jun 1st, 2023 11:00 am
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - May 25th, 2023 4:29 pm
Voyager Therapeutics Presents Robust, Multi-Species Results from Preclinical Studies of IV-Delivered, TRACER™-Generated Novel Capsids at the ASGCT 26th Annual Meeting - May 18th, 2023 10:00 am
Voyager Therapeutics (VYGR) Q1 Earnings and Revenues Surpass Estimates - May 9th, 2023 12:35 pm
Voyager Therapeutics Reports First Quarter 2023 Financial and Operating Results - May 9th, 2023 11:00 am
Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors - May 9th, 2023 10:55 am
Revenues Working Against Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Share Price - May 5th, 2023 10:08 am
Voyager Therapeutics (VYGR) Surges 11.1%: Is This an Indication of Further Gains? - May 4th, 2023 2:25 am
Voyager Therapeutics Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting - May 2nd, 2023 8:30 pm
Voyager Therapeutics Announces First Quarter 2023 Conference Call and Webcast - May 2nd, 2023 11:00 am
Companies Like Voyager Therapeutics (NASDAQ:VYGR) Can Afford To Invest In Growth - Apr 8th, 2023 1:12 pm
Voyager Therapeutics Presents New Data Supporting Tau Antibody Program for Alzheimer’s Disease and GBA1 Gene Therapy Program for Parkinson’s Disease at the AD/PD™ Conference - Mar 28th, 2023 11:00 am
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) top owners are individual investors with 29% stake, while 23% is held by institutions - Mar 12th, 2023 12:04 pm
Q4 2022 Voyager Therapeutics Inc Earnings Call - Mar 8th, 2023 8:03 am
Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates - Mar 7th, 2023 1:25 pm
Voyager Therapeutics Reports Fourth Quarter and Full Year 2022 Financial and Operating Results - Mar 7th, 2023 12:00 pm
Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets - Mar 6th, 2023 12:00 pm
Voyager Therapeutics Announces Fourth Quarter and Full Year 2022 Conference Call and Webcast - Feb 28th, 2023 12:00 pm
Zacks.com featured highlights include Las Vegas Sands, Voyager Therapeutics and nCino - Feb 13th, 2023 1:00 pm
3 Best Stocks to Invest in for Remarkable Earnings Acceleration - Feb 10th, 2023 11:23 am